Fall 2007 Grad Dr. Adam Fleisher was recently promoted to serve as Medical Director of Phase III Global Trials for Eli Lilly Alzheimer’s Disease team. He was previously Director of Global Medical Affairs for Eli Lilly. From 2008-2014 he was the Director of Imaging at Banner Alzheimer’s Institute where he managed the imaging center and cyclotron facility, the computational imaging laboratory, and functioned as a site investigator for dementia clinical trials. He continues to care for patients at the Banner Alzheimer’s Institute memory disorder clinic, and holds an academic appointment as an Associate Professor, Department of Neurosciences, at the University of California, San Diego, where he served as the Medical Director of the Alzheimer’s Disease Cooperative Study from 2003-2013. He received his medical degree from the University of Rochester School of Medicine, New York, and obtained his general neurology training at Johns Hopkins Hospital in Baltimore, Maryland. He then completed a clinical and research dementia fellowship at UC San Diego, as well as the Master of Advanced Studies degree in Clinical Research. He has published in both MRI and PET imaging (FDG and Amyloid), as well as clinical trials in Alzheimer’s disease, with a research focus on influences of aging and genetic risk factors for Alzheimer’s disease and predictive bio marker development in cognitively normal elderly adults.
“My MAS degree has played a key role in my career growth.” – Dr. Adam Fleisher